K M Grainger. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Dihydroxyphenylalanine/pharmacologyDihydroxyphenylalanine/therapeutic useHumansMaleMiddle AgedParkinson Disease/drug therapyPigmentation/drug effects
Substances: See more » Dihydroxyphenylalanine
Year: 1973 PMID: 4118669 DOI: 10.1016/s0140-6736(73)90490-x
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321